Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk - PubMed (original) (raw)

. 2019 Mar 20;37(9):689-692.

doi: 10.1200/JCO.18.01412. Epub 2019 Feb 11.

Affiliations

• PMID: 30742561
• DOI: 10.1200/JCO.18.01412

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Mitch Dowsett et al. J Clin Oncol. 2019.

No abstract available

PubMed Disclaimer

Comment in

• TAILORx: Questions Answered, Lessons Learned, and Remaining Knowledge Gaps.
  Sparano JA, Gray R. Sparano JA, et al. J Clin Oncol. 2019 Jul 20;37(21):1841-1842. doi: 10.1200/JCO.19.00828. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173552 Free PMC article. No abstract available.
• Reply to J.A. Sparano et al.
  Dowsett M, Turner N. Dowsett M, et al. J Clin Oncol. 2019 Jul 20;37(21):1842. doi: 10.1200/JCO.19.01147. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173555 No abstract available.

Similar articles

• A 23-gene prognostic classifier for prediction of recurrence and survival for Asian breast cancer patients.
  Chen TH, Chiu JY, Shih KH. Chen TH, et al. Biosci Rep. 2020 Dec 23;40(12):BSR20202794. doi: 10.1042/BSR20202794. Biosci Rep. 2020. PMID: 33226082 Free PMC article.
• The current clinical value of the DCIS Score.
  Wood WC, Alvarado M, Buchholz DJ, Hyams D, Hwang S, Manders J, Park C, Solin LJ, White J, Willey S. Wood WC, et al. Oncology (Williston Park). 2014 May;28 Suppl 2:C2, 1-8, C3. Oncology (Williston Park). 2014. PMID: 25375000
• Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools.
  Foldi J, O'Meara T, Marczyk M, Sanft T, Silber A, Pusztai L. Foldi J, et al. J Clin Oncol. 2019 Jun 1;37(16):1365-1369. doi: 10.1200/JCO.18.01933. Epub 2019 Apr 3. J Clin Oncol. 2019. PMID: 30943126 No abstract available.
• Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
  Kwon MJ. Kwon MJ. Arch Pharm Res. 2019 Nov;42(11):947-961. doi: 10.1007/s12272-019-01189-y. Epub 2019 Nov 9. Arch Pharm Res. 2019. PMID: 31707598 Review.
• Breast Molecular Profiling and Radiotherapy Considerations.
  Mahmoud O, Haffty BG. Mahmoud O, et al. Adv Exp Med Biol. 2016;882:95-124. doi: 10.1007/978-3-319-22909-6_4. Adv Exp Med Biol. 2016. PMID: 26987532 Review.

Cited by

• The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2- Breast Cancer.
  Wang M, Zhang M, Chen H. Wang M, et al. Adv Ther. 2023 Sep;40(9):3912-3925. doi: 10.1007/s12325-023-02566-2. Epub 2023 Jun 29. Adv Ther. 2023. PMID: 37382865
• Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2- breast cancer.
  Curigliano G, Dent R, Llombart-Cussac A, Pegram M, Pusztai L, Turner N, Viale G. Curigliano G, et al. NPJ Breast Cancer. 2023 Jun 28;9(1):56. doi: 10.1038/s41523-023-00560-z. NPJ Breast Cancer. 2023. PMID: 37380659 Free PMC article. Review.
• The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer.
  Chen K, Wu J, Fang Z, Shao X, Wang X. Chen K, et al. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221117402. doi: 10.1177/15330338221117402. Technol Cancer Res Treat. 2022. PMID: 36976899 Free PMC article. Review.
• Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors.
  Kujala J, Hartikainen JM, Tengström M, Sironen R, Auvinen P, Kosma VM, Mannermaa A. Kujala J, et al. Cancers (Basel). 2022 Mar 4;14(5):1332. doi: 10.3390/cancers14051332. Cancers (Basel). 2022. PMID: 35267640 Free PMC article.
• Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.
  Parikh PM, Bhattacharyya GS, Biswas G, Krishnamurty A, Doval D, Heroor A, Sharma S, Deshpande R, Chaturvedi H, Somashekhar SP, Babu G, Reddy GK, Sarkar D, Desai C, Malhotra H, Rohagi N, Bapna A, Alurkar SS, Krishna P, Deo SVS, Shrivastava A, Chitalkar P, Majumdar SK, Vijay D, Thoke A, Udupa KS, Bajpai J, Rath GK, Dattatreya PS, Bondarde S, Patil S. Parikh PM, et al. South Asian J Cancer. 2021 Dec 31;10(4):213-219. doi: 10.1055/s-0041-1742080. eCollection 2021 Dec. South Asian J Cancer. 2021. PMID: 34984198 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information